Ca2+-independent phospholipase A2-dependent sustained Rho-kinase activation exhibits all-or-none response

Genes to Cells

Volumn 11, Issue 9, 2006, Pages 1071-1083

  Maeda, Akio ^a   Ozaki, Yu Ichi ^a   Sivakumaran, Sudhir ^a,c   Akiyama, Tetsuro ^a   Urakubo, Hidetoshi ^a   Usami, Ayako ^a   Sato, Miharu ^a   Kaibuchi, Kozo ^b   Kuroda, Shinya ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SISSA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOENOL LACTONE; CALCIUM ION; MYOSIN LIGHT CHAIN; PHOSPHOLIPASE A2; PROTEIN SUBUNIT; RHO KINASE; THROMBIN; CALCIUM; MYOSIN LIGHT CHAIN PHOSPHATASE; PHOSPHOLIPASE A; PHOSPHOLIPASE A2 ALPHA; PHOSPHOLIPASE A2-ALPHA; PPP1R12A PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO-ASSOCIATED KINASE; SIGNAL PEPTIDE;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL DESIGN; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REPRODUCIBILITY; SIGNAL TRANSDUCTION; SYSTEM ANALYSIS; BIOLOGICAL MODEL; CELL CULTURE; COMPUTER SIMULATION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; METABOLISM; PHOSPHORYLATION;

CALCIUM; CELLS, CULTURED; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHOLIPASES A; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RHO GTP-BINDING PROTEINS; THROMBIN;

EID: 33747590405     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2006.01001.x     Document Type: Article

References (50)

1. 2. Biol. Pharm. Bull. 27, 1174-1178.
2. Amano, M., Ito, M., Kimura, K., Fukata, Y., Chihara, K., Nakano, T., Matsuura, Y. & Kaibuchi, K. (1996) Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271, 20246-20249.
3. Anderson, S., DiCesare, L., Tan, I., Leung, T. & SundarRaj, N. (2004) Rho-mediated assembly of stress fibers is differentially regulated in corneal fibroblasts and myofibroblasts. Exp. Cell Res. 298, 574-583.
4. Bagowski, C.P. & Ferrell, J.E. Jr (2001) Bistability in the JNK cascade. Curr. Biol. 11, 1176-1182.
5. Bahou, W.F., Coller, B.S., Potter, C.L., Norton, K.J., Kutok, J.L. & Goligorsky, M.S. (1993) The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation. J. Clin. Invest. 91, 1405-1413.
6. 2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages. Proc. Natl. Acad. Sci. U S A 92, 8527-8531.
7. Banga, H.S., Simons, E.R., Brass, L.F. & Rittenhouse, S.E. (1986) Activation of phospholipases A and C in human platelets exposed to epinephrine: Role of glycoproteins IIb/IIIa and dual role of epinephrine. Proc. Natl. Acad. Sci. USA 83, 9197-9201.
8. 2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J. Biol. Chem. 269, 15625-15630.
9. Bhalla, U.S. & Iyengar, R. (1999) Emergent properties of networks of biological signaling pathways. Science 283, 381-387.
10. Birukova, A.A., Smurova, K., Birukov, K.G., Kaibuchi, K., Garcia, J.G. & Verin, A.D. (2004) Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction. Microvasc. Res. 67, 64-77.
11. Bogatcheva, N.V., Garcia, J.G. & Verin, A.D. (2002) Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry 67, 75-84.
12. Borbiev, T., Verin, A.D., Birukova, A., Liu, F., Crow, M.T. & Garcia, J.G. (2003) Role of CaM kinase II and ERK activation in thrombin-induced endothelial cell barrier dysfunction. Am. J. Physiol. Lung Cell Mol. Physiol. 285, L43-L54.
13. Dudek, S.M. & Garcia, J.G. (2001) Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. 91, 1487-1500.
14. 2+-independent contraction in rat embryo fibroblasts. Am. J. Physiol. Cell Physiol. 286, C8-C21.
15. Essler, M., Amano, M., Kruse, H.J., Kaibuchi, K., Weber, P.C. & Aepfelbacher, M. (1998) Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J. Biol. Chem. 273, 21867-21874.
16. Favata, M.F., Horiuchi, K.Y., Manos, E.J., Daulerio, A.J., Stradley, D.A., Feeser, W.S., Van Dyk, D.E., Pitts, W.J., Earl, R.A., Hobbs, F., Copeland, R.A., Magolda, R.L., Scherle, P.A. & Trzaskos, J.M. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632.
17. Feng, J., Ito, M., Ichikawa, K., Isaka, N., Nishikawa, M., Hartshorne, D.J. & Nakano, T. (1999) Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J. Biol. Chem. 274, 37385-37390.
18. Ferrell, J.E. Jr (2002) Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr. Opin. Cell Biol. 14, 140-148.
19. Ferrell, J.E. Jr & Machleder, E.M. (1998) The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science 280, 895-898.
20. Forstermann, U., Alheid, U., Frolich, J.C. & Mulsch, A. (1988) Mechanisms of action of lipoxygenase and cytochrome P-450-mono-oxygenase inhibitors in blocking endothelium-dependent vasodilatation. Br. J. Pharmacol. 93, 569-578.
21. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S. & Otomo, S. (1994) NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47, 55-59.
22. Garcia, J.G., Davis, H.W. & Patterson, C.E. (1995) Regulation of endothelial cell gap formation and barrier dysfunction: Role of myosin light chain phosphorylation. J. Cell Physiol. 163, 510-522.
23. 2+ sensitization of contraction in vascular smooth muscle. J. Biol. Chem. 278, 1856-1863.
24. Kawano, Y., Fukata, Y., Oshiro, N., Amano, M., Nakamura, T., Ito, M., Matsumura, F., Inagaki, M. & Kaibuchi, K. (1999) Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J. Cell Biol. 147, 1023-1038.
25. Kawkitinarong, K., Linz-McGillem, L., Birukov, K.G. & Garcia, J.G. (2004) Differential regulation of human lung epithelial and endothelial barrier function by thrombin. Am. J. Respir. Cell Mol. Biol. 31, 517-527.
26. 2+ sensitization in triton X-100-demembranated rabbit arterial smooth muscle. J. Physiol. 520, 139-152.
27. Kolosova, I.A., Ma, S.F., Adyshev, D.M., Wang, P., Ohba, M., Natarajan, V., Garcia, J.G. & Verin, A.D. (2004) Role of CPI-17 in the regulation of endothelial cytoskeleton. Am. J. Physiol. Lung Cell Mol. Physiol. 287, L970-L980.
28. 2 enzymes. Prostaglandins Other Lipid Mediat. 68-69, 3-58.
29. Kuroda, S., Schweighofer, N., Amano, M., Kaibuchi, K. & Kawato, M. (2001) Distinct roles of Rho-kinase pathway and myosin light chain kinase pathway in phosphorylation of myosin light chain: Kinetic simulation study. In: Foundations of Systems Biology (ed. H. Kitano), pp. 279-294. Cambridge, MA: MIT Press.
30. Lukas, T.J. (2004a) A signal transduction pathway model prototype I: From agonist to cellular endpoint. Biophys. J. 87, 1406-1416.
31. 2+-calmodulin signaling and myosin light chain phosphorylation. Biophys. J. 87, 1417-1425.
32. Marshall, L.A., Winkler, J.D., Griswold, D.E., Bolognese, B., Roshak, A., Sung, C.M., Webb, E.F. & Jacobs, R. (1994) Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation. J. Pharmacol. Exp. Ther. 268, 709-717.
33. McHowat, J. & Creer, M.H. (2004) Catalytic features, regulation and function of myocardial phospholipase A2. Curr. Med. Chem. Cardiovasc. Hematol. Agents 2, 209-218.
34. Missy, K., Plantavid, M., Pacaud, P., Viala, C., Chap, H. & Payrastre, B. (2001) Rho-kinase is involved in the sustained phosphorylation of myosin and the irreversible platelet aggregation induced by PAR1 activating peptide. Thromb. Haemost. 85, 514-520.
35. Miyazaki, K., Yano, T., Schmidt, D.J., Tokui, T., Shibata, M., Lifshitz, L.M., Kimura, S., Tuft, R.A. & Ikebe, M. (2002) Rho-dependent agonist-induced spatio-temporal change in myosin phosphorylation in smooth muscle cells. J. Biol. Chem. 277, 725-734.
36. Murthy, K.S., Zhou, H., Grider, J.R., Brautigan, D.L., Eto, M. & Makhlouf, G.M. (2003) Differential signalling by muscarinic receptors in smooth muscle: M2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway. Biochem. J. 374, 145-155.
37. van Nieuw Amerongen, G.P., Draijer, R., Vermeer, M.A. & van Hinsbergh, V.W. (1998) Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: Role of protein kinases, calcium, and RhoA. Circ. Res. 83, 1115-1123.
38. van Nieuw Amerongen, G.P., Natarajan, K., Yin, G., Hoefen, R.J., Osawa, M., Haendeler, J., Ridley, A.J., Fujiwara, K., van Hinsbergh, V.W. & Berk, B.C. (2004) GIT1 mediates thrombin signaling in endothelial cells: role in turnover of RhoA-type focal adhesions. Circ. Res. 94, 1041-1049.
39. van Nieuw Amerongen, G.P., van Delft, S., Vermeer, M.A., Collard, J.G. & van Hinsbergh, V.W. (2000) Activation of RhoA by thrombin in endothelial hyperpermeability: Role of Rho kinase and protein tyrosine kinases. Circ. Res. 87, 335-340.
40. Pang, H., Guo, Z., Su, W., Xie, Z., Eto, M. & Gong, M.C. (2005) RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 289, C352-C360.
41. Ren, X.D., Kiosses, W.B. & Schwartz, M.A. (1999) Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18, 578-585.
42. Sandoval, R., Malik, A.B., Naqvi, T., Mehta, D. & Tiruppathi, C. (2001) Requirement for C2+ signaling in the mechanism of thrombin-induced increase in endothelial permeability. Am. J. Physiol. Lung Cell Mol. Physiol. 280, L239-L247.
43. Sasagawa, S., Ozaki, Y., Fujita, K. & Kuroda, S. (2005) Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat. Cell Biol. 7, 365-373.
44. Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., Loriolle, F., Duhamel, L., Charon, D. & Kirilovsky, J. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266, 15771-15781.
45. Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T., Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maekawa, M. & Narumiya, S. (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990-994.
46. Verin, A.D., Gilbert-McClain, L.I., Patterson, C.E. & Garcia, J.G. (1998) Biochemical regulation of the nonmuscle myosin light chain kinase isoform in bovine endothelium. Am. J. Respir. Cell Mol. Biol. 19, 767-776.
47. Winstead, M.V., Balsinde, J. & Dennis, E.A. (2000) Calcium-independent phospholipase A2: Structure and function. Biochim. Biophys. Acta 1488, 28-39.
48. Xiao, D., Longo, L.D. & Zhang, L. (2005) Alpha1-adrenoceptor-mediated phosphorylation of MYPT-1 and CPI-17 in the uterine artery: Role of ERK/PKC. Am. J. Physiol. Heart Circ. Physiol. 288, H2828-H2835.
49. Xiao, D., Pearce, W.J., Longo, L.D. & Zhang, L. (2004) ERK-mediated uterine artery contraction: Role of thick and thin filament regulatory pathways. Am. J. Physiol. Heart Circ. Physiol. 286, H1615-H1622.
50. Yazaki, A., Tamaru, S., Sasaki, Y., Komatsu, N., Wada, H., Shiku, H. & Nishikawa, M. (2005) Inhibition by Rho-kinase and protein kinase C of myosin phosphatase is involved in thrombin-induced shape change of megakaryocytic leukemia cell line UT-7/TPO. Cell. Signal. 17, 321-330.